Has Deborah Hustead received payments from drug or device companies?

Yes. Drug and device makers reported $4,132 in general payments to Deborah Hustead across 200 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Deborah Hustead did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Deborah Hustead come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Deborah Hustead

Physician Assistant · White Salmon, WANPI 1598902884

Payments from drug & device makers

$4,132in general payments, 2019–2025

Across 200 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$754
Novo Nordisk$645
Boehringer Ingelheim$473
Lilly USA, LLC$367
Amgen$349
Sanofi-aventis U.S. LLC$198
plus $1K from 20 others

What the payments were for

Food & beverage$4,121100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	22	$754
Novo Nordisk	34	$645
Boehringer Ingelheim	23	$473
Lilly USA, LLC	23	$367
Amgen	19	$349
Sanofi-aventis U.S. LLC	11	$198
AstraZeneca	8	$167
BD	7	$132
Insulet Corporation	6	$126
AbbVie	6	$124
Merck	5	$103
Dexcom, Inc.	5	$96
Xeris Pharmaceuticals, Inc.	4	$87
Bayer	4	$79
Radius Health, Inc.	3	$61
Corcept Therapeutics	3	$58
Medtronic	3	$52
Amarin Pharma, Inc.	3	$52
Novartis	2	$45
Biohaven Pharmaceutical Holding Company Ltd.	2	$42
Tandem Diabetes Care, Inc.	2	$40
Exact Sciences	1	$20
Daiichi Sankyo Inc.	1	$20
Zealand Pharma US, Inc.	1	$16
Lifescan, Inc.	1	$14
Bigfoot Biomedical Inc	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,132 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OzempicSemaglutide	26	$43,146
JardianceEmpagliflozin	23	$30,414
FarxigaDapagliflozin Propanediol	23	$24,419
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	13	$1,743
Rosuvastatin Calcium	26	$836
Metformin Hcl	43	$550
Atorvastatin Calcium	46	$361
Lisinopril	35	$287
Levothyroxine Sodium	19	$221
Omeprazole	13	$214
Metformin Hcl ErMetformin Hcl	14	$144
Amlodipine Besylate	22	$134
Pioglitazone Hcl	11	$128
Losartan Potassium	13	$124
Carvedilol	14	$80

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$645	$43,14626 claims
Boehringer IngelheimJardiance	$473	$30,41423 claims
AstraZenecaFarxiga	$167	$24,41923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in White Salmon

Jill KandoraShoreline$437K
Jeannette HartRichland$263K
Lance KeckTacoma$162K
Erinn KingSeattle$129K
Christy VathSeattle$75K
Scott TaylorMercer Island$71K
Gina FragioneGraham$69K
Regan BrownSpokane$56K
Justin ChapinSeattle$40K
Susan DuffyBellevue$23K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →